Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Longleaf Partners Small-Cap Fund Southeastern Asset Management, Inc. | “Healthcare insurance company Oscar was a contributor for the year as above-market membership growth and sustained expense discipline reinforced confidence in the company's positioning within the individual health insurance market. We exited our position in the third quarter as the P/V gap closed and industry risks became more apparent. The subsequent drama around the expiration of enhanced Affordable Care Act (ACA) subsidies underscores the ongoing policy uncertainty and challenges facing ACA-centric insurers like Oscar. Overall, the investment was successful for us, aided by management's execution through a volatile industry backdrop. BSD Analysis: Oscar is the rare insurtech that survived long enough to become boring — and that's the point. After years of chasing growth, management has shifted decisively toward profitability, risk discipline, and pricing sanity. Medical loss ratios are stabilizing, and cost controls are finally sticking. Oscar's tech-native model still offers structural advantages in engagement and data. The market treats Oscar like a failed disruptor, but the business is maturing into a viable niche insurer. It doesn't need to replace incumbents to win. Survival turned this into a real operating company.” | BULL | Q4 2025 Jan 1, 2026 | View Pitch |
Longleaf Partners Small-Cap Fund Southeastern Asset Management, Inc. | “Oscar Health – Health insurance and software company Oscar was a top contributor for the quarter. The company delivered a solid quarter operationally, effectively managing what was within its control despite market sentiment experiencing wild swings, largely driven by the latest draft of the Trump bill. We remain confident in the long-term potential for this company considering its differentiated offering for its members, and our aligned management partners who are on offense with a great balance sheet. That said, we trimmed our position this quarter when sentiment was most favorable. BSD Analysis: Oscar Health is a high-growth, disruptive insurtech pure-play whose stock is an asymmetric recovery bet on its successful pivot to GAAP profitability and its unique tech platform. The core moat is its cloud-native insurance operating system and its focus on the Individual and Small Group ACA markets. The company is converting its tech-driven efficiency into superior financial performance, with the Q3 2025 Medical Loss Ratio (MLR) improving to 83.1%. The stock is a high-risk, high-reward play on the successful execution of its cost-containment strategy and its ability to achieve positive free cash flow in the near future.” | BULL | Q2 2025 Jul 1, 2025 | View Pitch |
Longleaf Partners Small-Cap Fund Southeastern Asset Management, Inc. | “Oscar Health delivered strong revenue and membership growth, progressing toward its 5% operating income margin target. Despite regulatory uncertainty following the US presidential election, its underappreciated regional assets transition from investment mode to high-margin operations, representing significant embedded long-term growth.” | BULL | Q4 2024 Jan 1, 2025 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
